NCT02826486Phase 2Completed

Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients

Study sponsor: BioLineRx, Ltd. · BLRX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-09-06Actual
Enrollment · participants80Actual
Source updated2024-08-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview